Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 61.60
-0.70 (-1.12%)
Feb 11, 2026, 1:30 PM CST
Panion & Bf Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 174.37 | 124.52 | 77.22 | 182.35 | 104.4 | 27.9 |
Depreciation & Amortization | 141.75 | 164.42 | 170.39 | 163.55 | 143.62 | 84.14 |
Loss (Gain) From Sale of Assets | 0.13 | 0.1 | 0.38 | -6.28 | 0.44 | - |
Loss (Gain) From Sale of Investments | 0.98 | -1.46 | -7.5 | 93.68 | -6.72 | -5.79 |
Loss (Gain) on Equity Investments | -0.43 | 8.44 | 14.02 | 8.18 | 12.17 | 13.13 |
Stock-Based Compensation | - | - | - | - | 11.72 | - |
Provision & Write-off of Bad Debts | -1 | -0.33 | -1.05 | 0.08 | 2.09 | 3.45 |
Other Operating Activities | -19.23 | -16.02 | -27.98 | 44.15 | 8.81 | 1.69 |
Change in Accounts Receivable | -6.95 | 4.72 | 1.31 | -9.7 | 23.61 | 16.72 |
Change in Inventory | -26.68 | 12.62 | 7.12 | -15.88 | 32.33 | -97.28 |
Change in Accounts Payable | 0.45 | 19.8 | 8.21 | -5.69 | -31.94 | 18.33 |
Change in Other Net Operating Assets | 48.59 | 34.37 | -64.69 | 65.4 | 69.98 | -81.09 |
Operating Cash Flow | 311.98 | 351.19 | 177.42 | 489.87 | 401.23 | -14.56 |
Operating Cash Flow Growth | -17.94% | 97.94% | -63.78% | 22.09% | - | - |
Capital Expenditures | -142.75 | -185.69 | -181.23 | -198.64 | -170.01 | -101.16 |
Sale of Property, Plant & Equipment | 0 | 0.11 | 0.01 | 24.72 | - | - |
Cash Acquisitions | - | - | - | - | - | -544.37 |
Investment in Securities | 36.12 | 13.19 | 15.05 | 15 | -43.01 | -48.79 |
Other Investing Activities | 3.58 | 13.62 | 10.9 | 14.46 | -2.03 | 7.71 |
Investing Cash Flow | -103.05 | -158.77 | -155.27 | -144.47 | -215.05 | -686.61 |
Short-Term Debt Issued | - | 1,205 | 1,305 | 1,705 | 1,931 | 1,250 |
Long-Term Debt Issued | - | 59.24 | 117.86 | 22.9 | 54.38 | 673.95 |
Total Debt Issued | 988.95 | 1,264 | 1,423 | 1,728 | 1,985 | 1,924 |
Short-Term Debt Repaid | - | -1,240 | -1,165 | -1,575 | -2,131 | -1,109 |
Long-Term Debt Repaid | - | -45.41 | -31.12 | -181.61 | -634.13 | -31.61 |
Total Debt Repaid | -1,089 | -1,285 | -1,196 | -1,757 | -2,765 | -1,141 |
Net Debt Issued (Repaid) | -100 | -21.17 | 226.74 | -28.71 | -779.75 | 783.27 |
Issuance of Common Stock | - | - | - | - | 628.43 | - |
Common Dividends Paid | -154.33 | -128.61 | -171.48 | -128.61 | -53.72 | -138.13 |
Other Financing Activities | -15.9 | -20.73 | -6.6 | -10.07 | -12.72 | -1.93 |
Financing Cash Flow | -270.23 | -170.51 | 48.67 | -167.39 | -217.76 | 643.21 |
Foreign Exchange Rate Adjustments | -1.41 | 1.84 | -0.44 | 7.14 | 0.58 | 3.22 |
Net Cash Flow | -62.72 | 23.75 | 70.37 | 185.15 | -31.01 | -54.75 |
Free Cash Flow | 169.23 | 165.49 | -3.81 | 291.23 | 231.22 | -115.72 |
Free Cash Flow Growth | -10.83% | - | - | 25.95% | - | - |
Free Cash Flow Margin | 8.30% | 8.15% | -0.20% | 12.14% | 12.16% | -7.38% |
Free Cash Flow Per Share | 1.97 | 1.93 | -0.04 | 3.39 | 2.92 | -1.51 |
Cash Interest Paid | 15.05 | 14.61 | 11.08 | 7.64 | 14.7 | 4.27 |
Cash Income Tax Paid | 129.01 | 122.64 | 119.05 | 109.11 | 76.91 | 76.68 |
Levered Free Cash Flow | 168.84 | 93.15 | 46.79 | 300.67 | 187.8 | -183.4 |
Unlevered Free Cash Flow | 178.02 | 102.54 | 53.89 | 305.41 | 196.97 | -180.6 |
Change in Working Capital | 15.42 | 71.51 | -48.06 | 4.17 | 124.7 | -139.07 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.